• The Avicenna Alliance discussed upcoming activities

    The Avicenna Alliance board was convened by Secretary General Thierry Marchal on 23 March where board members around the world discussed the activities of the Alliance.

    FIND OUT MORE

  • Avicenna Alliance founding Sec Gen leaves legacy of policy success

    As the Avicenna Alliance enters its 3rd year of operation in 2018, it brings with it a change in management and a huge upscaling of activities.

    FIND OUT MORE

  • Avicenna Alliance continues to grow by welcoming Cipla among its members

    The latest company to join Avicenna Alliance is the pharmaceutical company Cipla.

    FIND OUT MORE

EU invests €1 billion in world-class European supercomputers

The Competitiveness Council (Council of Ministers) of the European Union adopted a Regulation to establish a Joint Undertaking of European...

find out more ›

More EU Member States join the 'Genomics Declaration'

On 21 September Croatia signed to join the European declaration on genomic data sharing. The Member State follows in the footsteps of Austria and...

find out more ›

'Plan S' and 'cOAlition S': joining forces to accelerate the transition to Open Access

On 4 September, Commissioner Moedas – who is in charge of Research, Science and Innovation – announced the...

find out more ›

The latest in a stream of new members

Avicenna Alliance is happy to announce the newest addition to its list of members: Optimo Medical AG. The Alliance is happy to welcome this Swiss-based European...

find out more ›

EU Commission steps up support for personalised medicine

In the past months, the EU has presented several initiatives that jointly have the potential to advance personalised medicine in Europe. Next...

find out more ›

In vivo, in vitro, in silico: Why computer modelling is the next evolution of the healthcare sector

International Conference on In Silico Medicine on 4 September

find out more ›

Cipla brings India perspectives on In Silico to Brussels

New Avicenna Member company Cipla shared some key insights on India’s perspective of In Silico medicine during a visit to Brussels in April....

find out more ›